| mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
9e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-05 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0001 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |